The Neurodegeneration Revolution: Emerging Therapies and Sustainable Solutions provides insights into the mechanics, characteristics, behavior, application, and manufacturing of advanced materials such as nanowires, 2D materials, biomaterials, smart materials, and more. The first section discusses the mechanics and electronic and magnetic properties of nanomaterials, photonic, and photonic materials and devices, 2D magnetic materials, smart materials and coatings, metamaterials, and microdevices and sensors. The second section of the book covers manufacturing technologies and methods of previously discussed materials, outlining manufacturing techniques for additive manufacturing of metallic lattice structures, biomedical alloys, shape memory alloys, multifunctional polymer composites, nanocomposite structures, ceramics, and batteries.

Table of Contents:

Section 1: Neurodegeneration and Basics 1. Introduction to Neurodegeneration 2. Mechanisms of Neurodegeneration 3. Risk Factors and Genetic Predisposition 4. Diagnosis and Management of Neurodegenerative Diseases Section 2: Established Therapies for Managing Neurodegeneration 5. Current Pharmacological Treatments 6. Non-Pharmacological Therapies 7. Nutritional Interventions 8. Lifestyle Changes for Neurodegeneration Prevention and Management Section 3: Advanced Therapies and Novel - New Age Delivery Systems 9. Gene Therapy for Neurodegeneration 10. Stem Cell Therapy for Neurodegeneration 11. Nanoparticle-Mediated Drug Delivery for Neurodegenerative Diseases 12. Exosomes and Extracellular Vesicles for Neurodegenerative Diseases Section 4: Sustainable Green Nanotechnology and Integration of AI/ML for Developing Nano Carriers 13. Sustainable green nanotechnology and its potential for developing nanocarriers for neurodegenerative diseases 14. AI/ML in the development of nanocarriers 15. Benefits of integrating sustainable green nanotechnology and AI/ML for the development of nanocarriers. 16. Challenges and ethical considerations Section 5: Emerging Frontiers in Neurodegenerative Disease Management 17. Biomarker research for neurodegenerative diseases 18. Ethical and social implications of managing neurodegenerative diseases 19. Caregivers and the management of neurodegenerative diseases 20. Global burden of neurodegenerative diseases Section 6: Clinical Trials and Recent Research, Future Directions, and Conclusion 21. Clinical Trials for Neurodegenerative Diseases 22. Recent Research in Neurodegenerative Diseases 23. Future Directions for Neurodegenerative Disease Management 24. Conclusion: Challenges and Opportunities in Neurodegenerative Diseases Management